| Rite Aid #10474 | |
| 4238 Harbor Beach Blvd, Brigantine, New Jersey 08203 | |
| (609) 266-8999 |
| Name | Rite Aid #10474 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 4238 Harbor Beach Blvd, Brigantine, New Jersey 08203 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (609) 266-8999 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Perth skin science technology company OBJ Limited is set to revolutionise treatment of joint injuries and osteoarthritis after its BodyGuard wearable patch product proved its superiority to the world-leading non-steroidal anti-inflammatory drug product Voltaren.
Researchers at the University of Tennessee, Knoxville, have identified a set of bacterial genes that may help them find ways to lessen the severity of the disease malaria.
Sudden infant death syndrome (SIDS) - the leading cause of death in infants under 1 year of age can happen at any time. But parents and caregivers should be extra careful during the cold winter months, when the flu and other infections and the urge to bundle up babies extra warmly increase the risk of SIDS, say experts from the Johns Hopkins Children's Center.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, presented preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.
› Verified 3 days ago
| NPI Number | 1699299933 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #19364 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4238 Harbor Beach Blvd, Brigantine, NJ 08203 |
| Phone Number | 609-266-8999 |
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Perth skin science technology company OBJ Limited is set to revolutionise treatment of joint injuries and osteoarthritis after its BodyGuard wearable patch product proved its superiority to the world-leading non-steroidal anti-inflammatory drug product Voltaren.
Researchers at the University of Tennessee, Knoxville, have identified a set of bacterial genes that may help them find ways to lessen the severity of the disease malaria.
Sudden infant death syndrome (SIDS) - the leading cause of death in infants under 1 year of age can happen at any time. But parents and caregivers should be extra careful during the cold winter months, when the flu and other infections and the urge to bundle up babies extra warmly increase the risk of SIDS, say experts from the Johns Hopkins Children's Center.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, presented preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.
› Verified 3 days ago
News Archive
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Perth skin science technology company OBJ Limited is set to revolutionise treatment of joint injuries and osteoarthritis after its BodyGuard wearable patch product proved its superiority to the world-leading non-steroidal anti-inflammatory drug product Voltaren.
Researchers at the University of Tennessee, Knoxville, have identified a set of bacterial genes that may help them find ways to lessen the severity of the disease malaria.
Sudden infant death syndrome (SIDS) - the leading cause of death in infants under 1 year of age can happen at any time. But parents and caregivers should be extra careful during the cold winter months, when the flu and other infections and the urge to bundle up babies extra warmly increase the risk of SIDS, say experts from the Johns Hopkins Children's Center.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, presented preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.
› Verified 3 days ago
Cvs Pharmacy #07096 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3313 Brigantine Blvd, Brigantine, New Jersey 08203 Phone: (609) 266-3260 | |
Rite Aid #10474 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4238 Harbor Beach Blvd, Brigantine, New Jersey 08203 Phone: (609) 266-8999 |